An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease-State of Art

Overview

Journal J Pers Med

Date 2022 May 28

PMID 35629130

Authors

Szymon Jonik

Michal Marchel

Zenon Huczek

Janusz Kochman

Radoslaw Wilimski

Mariusz Kusmierczyk

Marcin Grabowski

Grzegorz Opolski

Tomasz Mazurek

Affiliations

Soon will be listed here.

Abstract

The multidisciplinary Heart Team (HT) remains the standard of care for highly-burdened patients with coronary artery disease (CAD) and valvular heart disease (VHD) and is widely adopted in the medical community and supported by European and American guidelines. An approach of highly-experienced specialists, taking into account numerous clinical factors, risk assessment, long-term prognosis and patients preferences seems to be the most rational option for individuals with. Some studies suggest that HT management may positively impact adherence to current recommendations and encourage the incorporation of patient preferences through the use of shared-decision making. Evidence from randomized-controlled trials are scarce and we still have to satisfy with observational studies. Furthermore, we still do not know how HT should cooperate, what goals are desired and most importantly, how HT decisions affect long-term outcomes and patient's satisfaction. This review aimed to comprehensively discuss the available evidence establishing the role of HT for providing optimal care for patients with CAD and VHD. We believe that the need for research to recognize the HT definition and range of its functioning is an important issue for further exploration. Improved techniques of interventional cardiology, minimally-invasive surgeries and new drugs determine future perspectives of HT conceptualization, but also add new issues to the complexity of HT cooperation. Regardless of which direction HT has evolved, its concept should be continued and refined to improve healthcare standards.

References

Kezerle L, Yohanan E, Cohen A, Merkin M, Ishay Y, Weinstein J . The impact of Heart Team discussion on decision making for coronary revascularization in patients with complex coronary artery disease. J Card Surg. 2020; 35(10):2719-2724. DOI: 10.1111/jocs.14892. View

Heuts S, Olsthoorn J, Hermans S, Streukens S, Vainer J, Cheriex E . Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team. Neth Heart J. 2019; 27(4):176-184. PMC: 6439106. DOI: 10.1007/s12471-019-1238-1. View

Stone G, Lindenfeld J, Abraham W, Kar S, Lim D, Mishell J . Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018; 379(24):2307-2318. DOI: 10.1056/NEJMoa1806640. View

Banning A, Serruys P, De Maria G, Ryan N, Walsh S, Gonzalo N . Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2021; 43(13):1307-1316. PMC: 8970987. DOI: 10.1093/eurheartj/ehab703. View

Reardon M, Van Mieghem N, Popma J, Kleiman N, Sondergaard L, Mumtaz M . Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017; 376(14):1321-1331. DOI: 10.1056/NEJMoa1700456. View

Feldman T, Foster E, Glower D, Glower D, Kar S, Rinaldi M . Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364(15):1395-406. DOI: 10.1056/NEJMoa1009355. View

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C . 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019; 41(3):407-477. DOI: 10.1093/eurheartj/ehz425. View

Jonik S, Marchel M, Pedzich-Placha E, Pietrasik A, Rdzanek A, Huczek Z . Optimal Management of Patients with Severe Coronary Artery Disease following Multidisciplinary Heart Team Approach-Insights from Tertiary Cardiovascular Care Center. Int J Environ Res Public Health. 2022; 19(7). PMC: 8997622. DOI: 10.3390/ijerph19073933. View

Blankenship J, Mercado N . Treatment Recommendations for Patients With Multivessel Coronary Artery Disease-There Is No "I" in Heart Team, But Is the Heart Team Better Than the I?. JAMA Netw Open. 2020; 3(8):e2013098. DOI: 10.1001/jamanetworkopen.2020.13098. View

10.

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

11.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

12.

Rea C, Wang T, Ruygrok P, Sidhu K, Ramanathan T, Nand P . Characteristics and Outcomes of Patients With Severe Aortic Stenosis Discussed by the Multidisciplinary "Heart Team" According to Treatment Allocation. Heart Lung Circ. 2019; 29(3):368-373. DOI: 10.1016/j.hlc.2019.02.192. View

13.

Fihn S, Gardin J, Abrams J, Berra K, Blankenship J, Dallas A . 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on.... Circulation. 2012; 126(25):3097-137. DOI: 10.1161/CIR.0b013e3182776f83. View

14.

Jonik S, Marchel M, Pedzich-Placha E, Pietrasik A, Rdzanek A, Huczek Z . Long-term outcomes and quality of life following implementation of dedicated mitral valve Heart Team decisions for patients with severe mitral valve regurgitation in tertiary cardiovascular care center. Cardiol J. 2022; 31(1):62-71. PMC: 10919556. DOI: 10.5603/CJ.a2022.0011. View

15.

Horsted Thyregod H, Steinbruchel D, Ihlemann N, Nissen H, Kjeldsen B, Petursson P . Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015; 65(20):2184-94. DOI: 10.1016/j.jacc.2015.03.014. View

16.

Adams D, Popma J, Reardon M, Yakubov S, Coselli J, Deeb G . Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370(19):1790-8. DOI: 10.1056/NEJMoa1400590. View

17.

Mack M, Leon M, Smith C, Miller D, Moses J, Tuzcu E . 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2477-84. DOI: 10.1016/S0140-6736(15)60308-7. View

18.

Bakelants E, Belmans A, Verbrugghe P, Adriaenssens T, Jacobs S, Bennett J . Clinical outcomes of heart-team-guided treatment decisions in high-risk patients with aortic valve stenosis in a health-economic context with limited resources for transcatheter valve therapies. Acta Cardiol. 2018; 74(6):489-498. DOI: 10.1080/00015385.2018.1522461. View

19.

Young M, Kolte D, Cadigan M, Laikhter E, Sinclair K, Pomerantsev E . Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation. J Am Heart Assoc. 2020; 9(8):e014738. PMC: 7428540. DOI: 10.1161/JAHA.119.014738. View

20.

Head S, Davierwala P, Serruys P, Redwood S, Colombo A, Mack M . Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014; 35(40):2821-30. DOI: 10.1093/eurheartj/ehu213. View